EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Preoperative carbohydrate antigen 19-9 as a prognostic biomarker in colorectal cancer with synchronous peritoneal metastasis: multicentre cohort study

Keita Tashiro iD, Yoshiki Kajiwara, Hideki Ueno iD, Hirotoshi Kobayashi, Kenjiro Kotake, Kenichi Sugihara, Yoichi Ajioka

BJS Open · 12.05.2026 · 10 (3)

DOI: 10.1093/bjsopen/zrag060 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJS Open, online erschienen am 23.05.2026. Verfasst von Keita Tashiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Defence Medical College Hospital, Saitama, Japan. Hauptthemen laut MEDLINE: Biomarkers, Tumor, CA-19-9 Antigen, Colorectal Neoplasms, Peritoneal Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Society for Cancer of the Colon and Rectum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently, no international guidelines recommend carbohydrate antigen 19-9 (CA19-9) as a biomarker in colorectal cancer in clinical practice, although it has been reported that tumour cells with high affinity for peritoneal cells strongly express CA19-9. The aim of this study was to determine the utility of preoperative serum CA19-9 levels in predicting prognosis in patients with colorectal cancer and synchronous peritoneal metastasis.

Methods

Prognostic analyses were retrospectively performed in patients with colorectal cancer and synchronous peritoneal metastases who received treatment in 16 hospitals between 1991 and 2007 (Cohort 1). The categorization for CA19-9 and carcinoembryonic antigen were established based on the thresholds that minimized Akaike information criterion values for overall survival. A separate validation cohort of patients with synchronous peritoneal metastasis was prospectively registered across 28 institutions between 2012 and 2016 (Cohort 2) to validate these findings.

Results

A total of 689 patients were analysed in Cohort 1 and 144 in the validation Cohort 2. The categorized serum CA19-9 and carcinoembryonic antigen levels were significantly correlated with overall survival (P < 0.001 and P < 0.001, respectively). The median postoperative overall survival was 19.0 months for patients with a preoperative CA19-9 level < 100 U/ml compared with 4.1 months for those with a preoperative CA19-9 level of ≥ 10 000 U/ml. Using multivariable analysis, serum CA19-9, but not carcinoembryonic antigen, was an independent prognostic factor for overall survival. These results were confirmed in Cohort 2, revealing that the prognostic power of CA19-9 was superior to that of carcinoembryonic antigen.

Conclusions

Preoperative serum CA19-9 outperformed carcinoembryonic antigen as an independent prognostic biomarker in patients with colorectal cancer and peritoneal metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCA-19-9 AntigenColorectal NeoplasmsPeritoneal NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedCarcinoembryonic AntigenPreoperative PeriodPrognosisRetrospective Studies

Stichwörter der Autor:innen

CA19-9carcinoembryonic antigencolorectal cancerperitoneal metastasisprognostic biomarker

Substanzen

Biomarkers, TumorCA-19-9 AntigenCarcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Surgery, National Defence Medical College Hospital, Saitama, Japan.
  • Department of Surgery, Teikyo University Mizonokuchi Hospital, Kanagawa, Japan.
  • Department of Gastroenterology and Surgery, Sano City Hospital, Tochigi, Japan.
  • Institute of Science Tokyo, Tokyo, Japan.
  • Department of Division of Molecular and Diagnostic Pathology, Niigata University, Niigata, Japan.

ORCID-Profile: Keita Tashiro, Hideki Ueno

Förderung

  • Japanese Society for Cancer of the Colon and Rectum

Zitieren

APA

Tashiro, K., Kajiwara, Y., Ueno, H., Kobayashi, H., Kotake, K., Sugihara, K., & Ajioka, Y. (2026). Preoperative carbohydrate antigen 19-9 as a prognostic biomarker in colorectal cancer with synchronous peritoneal metastasis: multicentre cohort study. BJS Open, 10(3). https://doi.org/10.1093/bjsopen/zrag060

Vancouver

Tashiro K, Kajiwara Y, Ueno H, Kobayashi H, Kotake K, Sugihara K, et al. Preoperative carbohydrate antigen 19-9 as a prognostic biomarker in colorectal cancer with synchronous peritoneal metastasis: multicentre cohort study. BJS Open. 2026;10(3). doi:10.1093/bjsopen/zrag060

BibTeX
@article{Tashiro2026,
  author = {Tashiro, Keita and Kajiwara, Yoshiki and Ueno, Hideki and Kobayashi, Hirotoshi and Kotake, Kenjiro and Sugihara, Kenichi and Ajioka, Yoichi},
  title = {Preoperative carbohydrate antigen 19-9 as a prognostic biomarker in colorectal cancer with synchronous peritoneal metastasis: multicentre cohort study},
  journal = {BJS Open},
  year = {2026},
  volume = {10},
  number = {3},
  doi = {10.1093/bjsopen/zrag060}
}
Kostenlos starten →